Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Tumour stage is the strongest prognostic factor and the most …

Background Anatomical and molecular data can be acquired simultaneously through the
use of positron emission tomography (PET) in combination with computed tomography (CT) …

Positron emission tomography/computed tomography (PET/CT), with its metabolic data of
18F‐fluorodeoxyglucose (FDG) cellular uptake in addition to morphologic CT data, is an …

Lung cancer is a common disease and is a leading cause of death in many countries. The
management of lung cancer is directed by an optimal staging of the tumour. Integrated …

Positron emission tomography (PET) with 18F‐fluoro‐2‐deoxyglucose (FDG) has recently
emerged as a practical and useful imaging modality in patients with lung cancer. Malignant …

Lung cancer is the leading cause of cancer-related death. Accurate staging is essential for
the optimal management and treatment of these patients. Positron emission tomography …

Imaging plays an essential role in diagnosing, staging, and following patients with lung
cancer. Most tumors are found on chest radiographs, although further evaluation with …

Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …

Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …

Lung cancer is a common disease and the leading cause of cancer‐related death in many
countries. Precise staging of patients with non‐small‐cell lung cancer plays an important …